# Validation of a Novel Screening Test for Maternal Insulin Resistance

> **NCT03388697** · — · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 100 (actual)

## Conditions studied

- Insulin Resistance, Diabetes

## Interventions

- **DIAGNOSTIC_TEST:** Quantose IR and Quantose IGT analysis
- **DIAGNOSTIC_TEST:** HOMA IR the standard testing for insulin resistance

## Key facts

- **NCT ID:** NCT03388697
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-15
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388697, "Validation of a Novel Screening Test for Maternal Insulin Resistance". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03388697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*